What is LOPJLB’s current signal on JANX?

LOPJLB’s latest quantitative signal on Janux Therapeutics, Inc. (JANX) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is JANX in?

Janux Therapeutics, Inc. (JANX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Janux Therapeutics, Inc. (JANX) do?

Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, wh…

Where is Janux Therapeutics, Inc. based / listed?

Janux Therapeutics, Inc. is based in US, listed on NASDAQ.

Janux Therapeutics, Inc. (JANX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$18.39-0.59%Close

BUYRECOVERY · day 3

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1.1B
Beta: 2.39
P/E (TTM): -10.24

Short % float: 9.96%
Days to cover: 5.9
SI change: -3.5%

1W: +8.62%
1M: +4.02%

vs SPY 1W: +7.46%
vs SPY 1M: +1.02%

Industry peers

FMP comparable companies · ranked by market cap

LEGNSELLLegend Biotech Corporation$3.4BRECOVERYQ 2$18.62-0.48%
CLDXSELLCelldex Therapeutics, Inc.$2.0BCRISISQ 5$29.89+2.01%
IMNMSELLImmunome, Inc.$1.9BCRISISQ 18$19.55+1.24%
IMTXSELLImmatics N.V.$996MCRISISQ 6$7.43+0.81%
CGEMSELLCullinan Therapeutics, Inc.$954MCRISISQ 2$15.53+0.45%
CTMXSELLCytomX Therapeutics, Inc.$559MCRISISQ 7$2.57+4.05%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news